There's definately a different feeling in they say that "this is what we are going to do", then around the time indicated results showing it was done. Almost unheard of in pyc history lol. They have talked up huge developments for the next 6 months so it seems almost certain we will see much more data. As Akki says and I also wonder, the bottom line is do we have something others are prepared to pay for. Recent other deals might indicate yes if we can go above and beyond competitors abilities, but it would need to be a significant difference assuming the likes of sarepta or whoever are already getting into cells, may be just not as efficiently. Knowing these pharma if it is less efficient but no massive royalties to pay (which is what we are after) then maybe they stick with what they have.
PYC Price at posting:
3.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)